Held at the University of Melbourne’s Woodward Conference Centre via a hybrid model of delivery, the symposium will introduce researchers and clinicians to the wealth of research translation and commercialisation success stories from VCCC Alliance members and the rest of Victoria. Attendees will be invited to consider how their research can be translated to the clinic and ultimately improve cancer outcomes.
An inspiring program will explore lessons learned and practical advice drawn from success stories in the research translation and commercialisation space. Attendees will hear real-world examples of engaging with industry, developing research projects and collaborating with business development offices, encouraging you to think more strategically about how to progress to real world success.
Speakers will discuss topics including:
The forum will be followed by networking and drinks at the Woodward Centre.
Associate Professor Kara Britt is a VCA Mid-career Fellow and Group Leader at the Peter MacCallum Cancer Centre. Her work is focussed on the development of novel therapies for breast cancer prevention. She also co-chairs the VCCC Accelerating Novel Therapies to the clinic program with Jayesh Desai.
Sarah Churchill
Manager Industry Alliances and Partnerships
Peter MacCallum Cancer Centre
Lucy Pearce
Business Development Manager
Peter MacCallum Cancer Centre
Dr David Segal
Senior Business Development Manager
Walter and Eliza Hall Institute
Dr Michael Bettess
Senior Investment Manager, Brandon Capital
Sam Cobb
CEO, Currus Biologics
Professor Phil Darcy
Group Leader, Cancer Immunology Program, Peter MacCallum Cancer Centre
Dr Mark Devlin
CEO, Aculeus Therapeutics
Dr Ueli Nachbur
Scientist Entrepreneur, Ubiquitin Signaling Division, Walter and Eliza Hall Institute
Associate Professor Belinda Parker
Head of the Microenvironmental Crosstalk and Therapeutics Laboratory
Co-Head, Cancer Evolution and Metastasis Program, Peter MacCallum Cancer Centre
Dr Jai Rautela
Co-founder and CEO, oNKo-innate
Laboratory Head, Monash University
Professor Mimi Tang
CEO Prota Therapeutics
Director, Allergy Translation, Murdoch Children’s Research Institute
Consultant Immunologist Allergist, The Royal Children’s Hospital Melbourne; University of Melbourne
For further information please contact Thomas Pritchard, Project Officer - Accelerating Novel Therapies, VCCC Alliance [email protected]
